8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)
Published . Updated .
8-K - Akebia Therapeutics filed an 8-K with the SEC on Oct 23 (a notice of a material company event).
Directly affected
- AKBA Akebia Therapeutics-42.2%
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AKBA | +19.51% | +2.86% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-23 AccNo: 0001517022-26-000075 Size: 149 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Source: sec-edgar
Price since this story was published: Akebia Therapeutics (AKBA)
| Company | When | Move | Status |
|---|---|---|---|
| Akebia Therapeutics (AKBA) | three days earlier | +2.86% | final price |
| Akebia Therapeutics (AKBA) | five days earlier | +19.51% | final price |
| GLD | three days earlier | +3.41% | final price |
| GLD | five days earlier | +3.59% | final price |
| QQQ | three days earlier | +2.96% | final price |
| QQQ | five days earlier | +1.97% | final price |
| SPY | three days earlier | +1.68% | final price |
| SPY | five days earlier | +0.82% | final price |
| TLT | three days earlier | -1.30% | final price |
| TLT | five days earlier | -2.26% | final price |
Who is named in “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)”
Companies mentioned with this story
- AKBA Akebia Therapeutics
For “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer),” Akebia Therapeutics (AKBA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> AKBA
How “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)” reaches Akebia Therapeutics (AKBA)
Akebia Therapeutics (AKBA) is the company in “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer),” the 23 Oct 2026 this story story.
The link for Akebia Therapeutics (AKBA) is this: SEC 8-K filing -> direct issuer disclosure -> AKBA
Price levels for Akebia Therapeutics (AKBA)
AKBA traded between 0.54 and 1.04 across 12 sessions. The latest close on file is 0.56.
How solid “8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)” looks
14 out of 100
“8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.